Literature DB >> 3901264

Implications of kinetic heterogeneity in clinical oncology.

L Norton.   

Abstract

Mesh：

Year:  1985        PMID： 3901264

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  15 in total

1.  A quantitative study of growth variability of tumour cell clones in vitro.

Authors:  C Tomelleri; E Milotti; C Dalla Pellegrina; O Perbellini; A Del Fabbro; M T Scupoli; R Chignola
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

Review 2.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

Review 3.  Mathematical models of the steps involved in the systemic delivery of a chemotherapeutic to a solid tumor: From circulation to survival.

Authors:  Martin B Ulmschneider; Peter C Searson
Journal:  J Control Release       Date:  2015-06-20       Impact factor: 9.776

Review 4.  Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.

Authors:  M J Moore; C Erlichman
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

5.  Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.

Authors:  Costanza Paoletti; Maria C Muñiz; Dafydd G Thomas; Kent A Griffith; Kelley M Kidwell; Nahomi Tokudome; Martha E Brown; Kimberly Aung; M Craig Miller; Dorothy L Blossom; Anne F Schott; N Lynn Henry; James M Rae; Mark C Connelly; David A Chianese; Daniel F Hayes
Journal:  Clin Cancer Res       Date:  2014-11-07       Impact factor: 12.531

Review 6.  Translating mathematical modeling of tumor growth patterns into novel therapeutic approaches for breast cancer.

Authors:  Elizabeth Comen; Patrick G Morris; Larry Norton
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-09-26       Impact factor: 2.673

7.  A non-parametric method for the analysis of experimental tumour growth data.

Authors:  R Chignola; D Liberati; E Chiesa; C Anselmi; R Foroni; S Sartoris; A Brendolan; G Tridente; G Andrighetto
Journal:  Med Biol Eng Comput       Date:  1999-07       Impact factor: 2.602

8.  Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.

Authors:  R Demicheli; A Abbattista; R Miceli; P Valagussa; G Bonadonna
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 9.  The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications.

Authors:  C C Yu; A L Woods; D A Levison
Journal:  Histochem J       Date:  1992-03

10.  Should women with node-negative breast cancer receive adjuvant chemotherapy?--Insights from a decision analysis model.

Authors:  B E Hillner; T J Smith
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.